Genome analysis and polar tube firing dynamics of mosquito-infecting microsporidia.

E. Troemel,J. Becnel

DOI: https://doi.org/10.1016/j.fgb.2015.08.007

IF: 3.883

2015-10-01

Fungal Genetics and Biology

Abstract:

What problem does this paper attempt to address?

Vitamin E limits AAA.

R. Dalman

Abstract:
The gut microbiota in osteoarthritis: where do we stand and what can we do?

Xiaoxia Hao,Xingru Shang,Jiawei Liu,Ruimin Chi,Jiaming Zhang,Tao Xu

DOI: https://doi.org/10.1186/s13075-021-02427-9

2021-01-27

Abstract:Abstract Osteoarthritis (OA) is one of the most frequent musculoskeletal diseases characterized by degeneration of articular cartilage, subchondral bone remodeling, and synovial membrane inflammation, which is a leading cause of global disability, morbidity, and decreased quality of life. Interpreting the potential mechanisms of OA pathogenesis is essential for developing novel prevention and disease-modifying therapeutic interventions. Gut microbiota is responsible for a series of metabolic, immunological, and structural and neurological functions, potentially elucidating the heterogeneity of OA phenotypes and individual features. In this narrative review, we summarized research evidence supporting the hypothesis of a “gut-joint axis” and the interaction between gut microbiota and the OA-relevant factors, including age, gender, genetics, metabolism, central nervous system, and joint injury, elucidating the underlying mechanisms of this intricate interaction. In the context, we also speculated the promising manipulation of gut microbiota in OA management, such as exercise and fecal microbiota transplantation (FMT), highlighting the clinical values of gut microbiota. Additionally, future research directions, such as more convincing studies by the interventions of gut microbiota, the gene regulation of host contributing to or attributed to the specific phenotypes of gut microbiota related to OA, and the relevance of distinct cell subgroups to gut microbiota, are expected. Moreover, gut microbiota is also the potential biomarker related to inflammation and gut dysbiosis that is able to predict OA progression and monitor the efficacy of therapeutic intervention.

rheumatology
Gut microbiota and osteoarthritis management: An expert consensus of the European society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO)

Emmanuel Biver,Francis Berenbaum,Ana M Valdes,Islene Araujo de Carvalho,Laure B Bindels,Maria Luisa Brandi,Philip C Calder,Vincenzo Castronovo,Etienne Cavalier,Antonio Cherubini,Cyrus Cooper,Elaine Dennison,Claudio Franceschi,Nicholas Fuggle,Andrea Laslop,Pierre Miossec,Thierry Thomas,Sansin Tuzun,Nicola Veronese,Mila Vlaskovska,Jean-Yves Reginster,René Rizzoli,Ana M. Valdes,Laure B. Bindels,Philip C. Calder

DOI: https://doi.org/10.1016/j.arr.2019.100946

IF: 11.788

2019-11-01

Ageing Research Reviews

Abstract:The prevalence of osteoarthritis (OA) increases not only because of longer life expectancy but also because of the modern lifestyle, in particular physical inactivity and diets low in fiber and rich in sugar and saturated fats, which promote chronic low-grade inflammation and obesity. Adverse alterations of the gut microbiota (GMB) composition, called microbial dysbiosis, may favor metabolic syndrome and inflammaging, two important components of OA onset and evolution. Considering the burden of OA and the need to define preventive and therapeutic interventions targeting the modifiable components of OA, an expert working group was convened by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) to review the potential contribution of GMB to OA. Such a contribution is supported by observational or dietary intervention studies in animal models of OA and in humans. In addition, several well-recognized risk factors of OA interact with GMB. Lastly, GMB is a critical determinant of drug metabolism and bioavailability and may influence the response to OA medications. Further research targeting GMB or its metabolites is needed to move the field of OA from symptomatic management to individualized interventions targeting its pathogenesis.

cell biology,geriatrics & gerontology,gerontology
Association Between Gut Microbiota and Osteoarthritis: A Review of Evidence for Potential Mechanisms and Therapeutics

Zhentian Wei,Feng Li,Guofu Pi

DOI: https://doi.org/10.3389/fcimb.2022.812596

IF: 6.073

2022-03-16

Frontiers in Cellular and Infection Microbiology

Abstract:Osteoarthritis (OA) is a multifactorial joint disease characterized by degeneration of articular cartilage, which leads to joints pain, disability and reduced quality of life in patients with OA. Interpreting the potential mechanisms underlying OA pathogenesis is crucial to the development of new disease modifying treatments. Although multiple factors contribute to the initiation and progression of OA, gut microbiota has gradually been regarded as an important pathogenic factor in the development of OA. Gut microbiota can be regarded as a multifunctional “organ”, closely related to a series of immune, metabolic and neurological functions. This review summarized research evidences supporting the correlation between gut microbiota and OA, and interpreted the potential mechanisms underlying the correlation from four aspects: immune system, metabolism, gut-brain axis and gut microbiota modulation. Future research should focus on whether there are specific gut microbiota composition or even specific pathogens and the corresponding signaling pathways that contribute to the initiation and progression of OA, and validate the potential of targeting gut microbiota for the treatment of patients with OA.

immunology,microbiology
The Gut-Joint Axis in Osteoarthritis

Madhan Jeyaraman,Pothuri Rishi Ram,Naveen Jeyaraman,Sankalp Yadav,Rishi Ram

DOI: https://doi.org/10.7759/cureus.48951

2023-11-17

Cureus

Abstract:Osteoarthritis (OA) is a complex and prevalent joint disease with a multifaceted pathogenesis, presenting a persistent challenge to medical researchers. However, recent investigations into the gut microbiota (GMB) have unveiled an intriguing connection with OA, giving rise to the concept of the "gut-joint axis". The human gut houses a diverse microbial ecosystem that plays pivotal roles in nutrient synthesis, metabolism, and immune modulation. Dysbiosis, or disruption of this microbial balance, can lead to inflammation through the release of proinflammatory cytokines and the production of inflammatory metabolites. This editorial delves into the evolving understanding of how the GMB may influence OA development and progression. Notably, short-chain fatty acids (SCFAs) produced by gut microorganisms have emerged as potential players in maintaining bone homeostasis and reducing inflammation. Furthermore, compromised gut integrity can lead to endotoxemia and a pro-inflammatory state, contributing to OA. Recent research has highlighted differences in GMB composition and functionality between OA patients and healthy individuals, shedding light on specific microbial taxa and functional pathways associated with OA. The gut mycobiome (fungi) and virome (viruses) in OA remain largely unexplored, presenting exciting opportunities for future investigations. The emerging understanding of the gut-joint axis offers promising avenues for innovative OA prevention and treatment strategies, though further research is needed to fully elucidate these complex interactions.
The effects and significance of gut microbiota and its metabolites on the regulation of osteoarthritis: Close coordination of gut-bone axis

Lei Liu,Feng Tian,Guo-Yuan Li,Wei Xu,Rui Xia

DOI: https://doi.org/10.3389/fnut.2022.1012087

2022-09-20

Abstract:Osteoarthritis (OA) is a common chronic degenerative disease of articular cartilage in middle-aged and older individuals, which can result in the joint pain and dysfunction, and even cause the joint deformity or disability. With the enhancing process of global aging, OA has gradually become a major public health problem worldwide. Explaining pathogenesis of OA is critical for the development of new preventive and therapeutic interventions. In recent years, gut microbiota (GM) has been generally regarded as a "multifunctional organ," which is closely relevant with a variety of immune, metabolic and inflammatory functions. Meanwhile, more and more human and animal researches have indicated the existence of gut-bone axis and suggested that GM and its metabolites are closely involved in the pathogenic process of OA, which might become a potential and promising intervention target. Based on the close coordination of gut-bone axis, this review aims to summarize and discuss the mechanisms of GM and its metabolites influencing OA from the aspects of the intestinal mucosal barrier modulation, intestinal metabolites modulation, immune modulation and strategies for the prevention or treatment of OA based on perspectives of GM and its metabolites, thus providing a profound knowledge and recognition of it.
Gut-joint axis: Oral Probiotic ameliorates Osteoarthritis

Uzma Amin,Rong Jiang,Shahid Masood Raza,Mengtian Fan,Li Liang,Naibo Feng,Xiaoli Li,Yuyou Yang,Fengjin Guo

DOI: https://doi.org/10.1016/j.jtcme.2023.06.002

2023-06-20

Abstract:Osteoarthritis (OA) etiology is multifactorial, and its prevalence is growing globally. The Gut microbiota shapes our immune system and impacts all aspects of health and disease. The idea of utilizing probiotics to treat different conditions prevails. Concerning musculoskeletal illness and health, current data lack the link to understand the interactions between the host and microbiome. We report that S. thermophilus, L. pentosus (as probiotics), and γ-aminobutyric acid (GABA) harbour against osteoarthritis in vivo and alleviate IL-1β induced changes in chondrocytes in vitro. We examined the increased GABA concentration in mice's serum and small intestine content followed by bacterial treatment. The treatment inhibited the catabolism of cartilage and rescued mice joints from degradation. Furthermore, the anabolic markers upregulated and decreased inflammatory markers in mice knee joints and chondrocytes. This study is the first to represent GABA's chondrogenic and chondroprotective effects on joints and human chondrocytes. This data provides a foundation for future studies to elucidate the role of GABA in regulating chondrocyte cell proliferation. These findings opened future horizons to understanding the gut-joint axis and OA treatment. Thus, probiotic/GABA therapy shields OA joints in mice and could at least serve as adjuvant therapy to treat osteoarthritis.
The gut microbiome-joint connection: implications in osteoarthritis

Lacey J Favazzo,Honey Hendesi,David A Villani,Sarah Soniwala,Qurratul-Ain Dar,Eric M Schott,Steven R Gill,Michael J Zuscik

DOI: https://doi.org/10.1097/BOR.0000000000000681

Abstract:Purpose of review: Osteoarthritis is a debilitating disease leading to joint degeneration, inflammation, pain, and disability. Despite efforts to develop a disease modifying treatment, the only accepted and available clinical approaches involve palliation. Although many factors contribute to the development of osteoarthritis, the gut microbiome has recently emerged as an important pathogenic factor in osteoarthritis initiation and progression. This review examines the literature to date regarding the link between the gut microbiome and osteoarthritis. Recent findings: Studies showing correlations between serum levels of bacterial metabolites and joint degeneration were the first links connecting a dysbiosis of the gut microbiome with osteoarthritis. Further investigations have demonstrated that microbial community shifts induced by antibiotics, a germ-free environment or high-fat are important underlying factors in joint homeostasis and osteoarthritis. It follows that strategies to manipulate the microbiome have demonstrated efficacy in mitigating joint degeneration in osteoarthritis. Moreover, we have observed that dietary supplementation with nutraceuticals that are joint protective may exert their influence via shifts in the gut microbiome. Summary: Although role of the microbiome in osteoarthritis is an area of intense study, no clear mechanism of action has been determined. Increased understanding of how the two factors interact may provide mechanistic insight into osteoarthritis and lead to disease modifying treatments.
The immune role of the intestinal microbiome in knee osteoarthritis: a review of the possible mechanisms and therapies

Chang Sun,Xing Zhou,Ting Guo,Jia Meng

DOI: https://doi.org/10.3389/fimmu.2023.1168818

IF: 7.3

2023-06-14

Frontiers in Immunology

Abstract:Osteoarthritis (OA) is a chronic degenerative joint disease characterized by cartilage damage and synovial inflammation and carries an enormous public health and economic burden. It is crucial to uncover the potential mechanisms of OA pathogenesis to develop new targets for OA treatment. In recent years, the pathogenic role of the gut microbiota in OA has been well recognized. Gut microbiota dysbiosis can break host-gut microbe equilibrium, trigger host immune responses and activate the “gut-joint axis”, which aggravates OA. However, although the role of the gut microbiota in OA is well known, the mechanisms modulating the interactions between the gut microbiota and host immunity remain unclear. This review summarizes research on the gut microbiota and the involved immune cells in OA and interprets the potential mechanisms for the interactions between the gut microbiota and host immune responses from four aspects: gut barrier, innate immunity, adaptive immunity and gut microbiota modulation. Future research should focus on the specific pathogen or the specific changes in the gut microbiota composition to identify the related signaling pathways involved in the pathogenesis of OA. In addition, future studies should include more novel interventions on immune cell modifications and gene regulation of specific gut microbiota related to OA to validate the application of gut microbiota modulation in the onset of OA.

immunology
[Evaluation of the results of fluoridation of rat teeth by impregnation and electrophoresis].

J. Leźovic,L. Hegedüs,G. Hocman

1971-03-01

Abstract:
Potential efficacy of gut microbiome dysbiosis on alleviation the progress of osteoarthritis in mice

zhiyuan Guan,Jialin Jia,Chenggui Zhang,Tiantong Sun,Wang Zhang,Huijie Leng,Chunli Song

DOI: https://doi.org/10.21203/rs.3.rs-28047/v1

2020-01-01

Abstract:Abstract ObjectiveTo evaluate the relationship between the gut microbiota dysbiosis and progression of osteoarthritis (OA)DesignWe used a mice OA model (8 weeks) of destabilization of medial meniscus and the gut microbiome dysbiosis induced by antibiotic treatment(ABT) with ampicillin and neomycin for 8 weeks. The severity of OA was evaluated by micro-CT, X-ray and histology of osteoarthritis Research International (OARSI) score. Microbiome analysis by 16 s DNA qPCR was performed on the feces samples and the serum IL-6, TNF-α, osteocalcin, estrogen, calcium and magnesium ion were measured in enzyme-linked immunosorbent assay(ELISA).ResultCompare to the normal mice, the bone volume over total volume(BV/TV)(P < 0.01 for both subgroup analysis) and the osteoarthritis Research International (OARSI) score (P < 0.01 for both subgroup analysis) and in subchondral bone and was decreased significant in ABT treatment of female and male group. ABT decreased the osteophyte score in female mice with standard normal group(P < 0.05) and also declined osteophyte maturity score in both female(P < 0.01) and male(P < 0.05)mice. The level of IL-6(P < 0.01 for both subgroup analysis), TNF-α(P < 0.01 for both subgroup) and calcium(P < 0.01 for both subgroup analysis) were decreased significant in ABT group than control group while the magnesium(P < 0.01 for both subgroup analysis) and estrogen(P < 0.01 for both subgroup analysis) were increased significant in ABT female group than that in the control female group. Pearson’s correlation analyses demonstrated that subchondral bone BV/TV(r = -0.6145, P = 0.0001) and OARSI score in medial tibial plateau(r = -0.5407, P = 0.0007) are negatively correlated with the Firmicutes : Bacteroidetes ratio.ConclusionGut microbiome dysbiosis have a potential efficacy on alleviate the progress of OA.
Gut permeability and osteoarthritis, towards a mechanistic understanding of the pathogenesis: a systematic review

Giorgio Guido,Guido Ausenda,Veronica Iascone,Emanuele Chisari

DOI: https://doi.org/10.1080/07853890.2021.2014557

IF: 5.348

2021-01-01

Annals of Medicine

Abstract:Osteoarthritis (OA) is the most common condition affecting human joints. Along with mechanical and genetic factors, low-grade inflammation is increasingly supported as a causal factor in the development of OA. Gut microbiota and intestinal permeability, via the disruption of tight junction competency, are proposed to explain a gut-joint axis through the interaction with the host immune system. Since previous studies and methods have underestimated the role of the gut-joint axis in OA and have only focussed on the characterisation of microbiota phenotypes, this systematic review aims to appraise the current evidence concerning the influence of gut permeability in the pathogenesis of OA. We propose that the tight junction disruption may be due to an increase in zonulin activity as already demonstrated for many other chronic inflammatory disorders. After years of unreliable quantification, one study optimised the methodology, showing a positive validated correlation between plasma lipopolysaccharide (LPS), obesity, joint inflammation, and OA severity. Chemokines show a prominent role in pain development. Our systematic review confirms preliminary evidence supporting a gut-joint axis in OA pathogenesis and progression. Being modifiable by several factors, the gut microbiota is a promising target for treatment. We propose a pathogenetic model in which dysbiosis is correlated to the bipartite graph of tight junctions and bacterially-produced products, aiming to direct future studies in the search of other bacterial products and tight junction disassembly regulators.KEY MESSAGESPrevious studies and methods have underestimated the impact of the gut-joint axis in osteoarthritis and have focussed on the characterisation of microbiota phenotypes rather than clear molecular mediators of disease.Gut dysbiosis is related to higher levels of bacterial toxins that elicit cartilage and synovium inflammatory pathways.Future research may benefit from focussing on both tight junctions and bacterially-produced products.

medicine, general & internal
The Microbiome in Osteoarthritis: a Narrative Review of Recent Human and Animal Model Literature

Christopher M Dunn,Matlock A Jeffries

DOI: https://doi.org/10.1007/s11926-022-01066-6

Abstract:Purpose of the review: The microbiome has recently emerged as a powerful contributor to health and illness in chronic, systemic disorders. Furthermore, new microbiome niches beyond traditional gut locations are frequently being described. Over the past 5 years, numerous pivotal studies have demonstrated associations between changes in various microbiome niches and the development of osteoarthritis (OA). Herein, we review the most impactful recent literature, including microbiome associations with disease and the potential therapeutic value of microbiome manipulation. Recent findings: The gut microbiome of human OA patients is enriched in specific bacterial clades, most notably Streptococcus, which correlates with OA pain, Firmicutes, and others. Most studies have focused on knee OA, although one publication demonstrated positive associations with 3 gut microbiome clades in hand OA. OA can be easily distinguished from RA by evaluating differences in oral microbiome composition. Most studies have also demonstrated a reduction in richness of the gut microbiome (alpha diversity) associated with OA. Several studies have identified bacterial signatures within human knee and hip cartilage, synovial fluid, and synovial tissue and have described changes in these patterns occurring with the development of OA. In animal models of OA, high-fat diet-induced obesity has been the most well-studied OA risk factor associated with changes in the microbiome, with numerous bacterial clades changed within the gut microbiome and associated with OA. Also in animal models, various oral supplementations, including dietary fiber, probiotics including Lactobacillus species, and cecal microbiome transplantation have all shown improvements in OA histopathology or cartilage healing. Microbiome changes are strongly associated with the OA disease process and with individual OA risk factors related to both the gut microbiome and the microbial DNA patterns in the joint. Microbiome-directed interventions have the potential to prevent or reduce the progression of OA. Future studies should investigate the mechanistic underpinnings of these microbiome associations and further define the therapeutic potential of microbiome augmentation.
Resonant effects in periodic gratings comprising a finite number of grooves in each period.

Á. N. Fantino,S. I. Grosz,D. Skigin

DOI: https://doi.org/10.1103/PHYSREVE.64.016605

2001-06-20

Abstract:We give numerical evidence of a kind of resonance that appears in infinite perfectly conducting gratings comprising a finite number of grooves in each period when illuminated by a normally incident p-polarized plane wave. This phenomenon is intimately connected with the particular distribution of the phase of the electromagnetic field inside the cavities, which is automatically generated by waves of certain resonant wavelengths. The resonances appear as sharp peaks in the specularly reflected efficiency and are accompanied by a significant intensification of the interior field. We study the particular case of rectangular cavities and consider configurations with different numbers of grooves per period. The diffraction problem is solved for s and p polarization by using the modal method, which proves to be especially suitable for this profile.
"Cross-talk" between gut microbiome dysbiosis and osteoarthritis progression: a systematic review

Su Liu,Guoqing Li,Huihui Xu,Qichang Wang,Yihao Wei,Qi Yang,Ao Xiong,Fei Yu,Jian Weng,Hui Zeng

DOI: https://doi.org/10.3389/fimmu.2023.1150572

2023-04-25

Abstract:Objectives: The aim of this systematic review was to summarize the available literature on gut microbiome (GMB) and osteoarthritis (OA), analyze the correlation between GMB and OA, and explore potential underlying mechanisms. Methods: A systematic search of the PubMed, Embase, Cochrane, and Web of Science with the keywords "Gut Microbiome" and "Osteoarthritis" was conducted to identify the human and animal studies exploring the association between GMB and OA. The retrieval time range was from the database inception to July 31, 2022. Studies reported the other arthritic diseases without OA, reviews, and studies focused on the microbiome in other parts of the body with OA, such as oral or skin, were excluded. The included studies were mainly reviewed for GMB composition, OA severity, inflammatory factors, and intestinal permeability. Results: There were 31 studies published met the inclusion criteria and were analyzed, including 10 human studies and 21 animal studies. Human and animal studies have reached a consistent conclusion that GMB dysbiosis could aggravate OA. In addition, several studies have found that alterations of GMB composition can increase intestinal permeability and serum levels of inflammatory factors, while regulating GMB can alleviate the changes. Owing to the susceptibility of GMB to internal and external environments, genetics, and geography, the included studies were not consistent in GMB composition analysis. Conclusion: There is a lack of high-quality studies evaluating the effects of GMB on OA. Available evidence indicated that GMB dysbiosis aggravated OA through activating the immune response and subsequent induction of inflammation. Future studies should focus on more prospective, cohort studies combined with multi-omics to further clarify the correlation.
Identification and initial characterization of small cells in adult cartilage and bone marrow.

Min‐Huey Chen,Shiming Lin,Chang-Hsun Hsieh,Hsuan-Shu Lee,H. Chiang,Ching-Chuan Jiang

DOI: https://doi.org/10.29828/JFMA.200404.0003

2004-04-01

Journal of the Formosan Medical Association = Taiwan yi zhi

Abstract:BACKGROUND AND PURPOSE Small cells in the range of less than 5 microm have been suspected to lie dormant and to be dispersed throughout the parenchyma of every tissue in the body. In bone marrow, small mesenchymal stem cells with rapidly renewing properties and differentiation potentials have been found. The aim of this study was to isolate and identify small cells from normal and osteoarthritic cartilages and compare their properties with those of small stem cells in bone marrow. METHODS Small cells were isolated from cartilages and bone marrow. Characterization of these small cells was performed by hematoxylin and eosin staining and bromodeoxyuridine labeling. Scanning electron and atomic force microscopy were used for ultrastructural investigation and analysis of the cells. RESULTS Small cells (< or = 5 microm) from both cartilages and bone marrow were shown to have mitotic activity on the basis of bromodeoxyuridine labeling, with the same replication time of 18 to 20 hours for population doubling. Ultrastructural and atomic force microscopy revealed these cells had spherical shape and were about 0.2 to 2.2 microm in diameter. CONCLUSIONS This study demonstrated the presence of small cells in adult cartilage and bone marrow, which were about 0.2 to 2.2 microm in diameter and exhibited proliferation potential. These cells were able to be activated and differentiate into chondrocytes, and might have differentiation potential similar to small stem cells in bone marrow and thus play an important role in cartilage regeneration.
Gut Microbiome Dysbiosis Alleviates He Progression Of Osteoarthritis In Mice

Zhiyuan Guan,Jialin Jia,Chenggui Zhang,Tiantong Sun,Wang Zhang,Wanqiong Yuan,Huijie Leng,Chunli Song

DOI: https://doi.org/10.2139/ssrn.3696788

2020-01-01

Clinical Science

Abstract:Gut microbiota dysbiosis has been studied under the pathological conditions of osteoarthritis (OA). However, the effect of antibiotic-induced gut flora dysbiosis on OA remains incompletely understood at present. Herein, we used a mouse (8 weeks) OA model of destabilization of the medial meniscus (DMM) and gut microbiome dysbiosis induced by antibiotic treatment with ampicillin and neomycin for 8 weeks. The results show that antibiotic-induced intestinal microbiota dysbiosis reduced the serum level of lipopolysaccharide (LPS) and the inflammatory response, such as suppression of the levels of tumour necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6), which can lead to decreased matrix metalloprotease-13 (MMP-13) expression and improvement of OA after joint injury. In addition, trabecular thickness (Tb.Th) and osteophyte scores were increased significantly in antibiotic-induced male mice compared with female mice. We further used network correlation analysis to verify the effect of gut microbiota dysbiosis on OA. Therefore, the present study contributes to our understanding of the gut-joint axis in OA and reveals the relationship between the inflammatory response, sex and gut microbiota, which may provide new strategies to prevent the symptoms and long-term sequelae of OA.Conclusion: Our data showed that gut microbiome dysbiosis alleviates the progression of OA.
The Gut Microbiota of Rats under Experimental Osteoarthritis and Administration of Chondroitin Sulfate and Probiotic

O.H. Korotkyi,T.V. Luhovska,T.M. Serhiychuk,K.O. Dvorshchenko,T.M. Falalyeyeva,L.I. Ostapchenko,,,,,,

DOI: https://doi.org/10.15407/microbiolj82.06.064

2020-11-30

Mikrobiolohichnyi Zhurnal

Abstract:Osteoarthritis is a most widespread chronic degenerative joint disease that causes pain, cartilage deformation, and joint inflammation. Adverse alterations of intestinal microbiota like dysbiosis may lead to metabolic syndrome and inflammation, two important components of osteoarthritis progression. Aim. In this study we investigated the effect of chondroitin sulfate and probiotics on the gut microbiome in monoiodoacetate-induced osteoarthritis model in rats. Methods. The species and quantitative composition of feces were determined using diagnostic media with selective properties. Further identification of isolated microorganisms was carried out according to morphological, tinctorial, physiological and metabolic parameters. The results are presented in the form of lg CFU/g. Results. Induction of osteoarthritis caused significant increasing the number of opportunistic enterobacteria and lactose-negative Escherichia coli against the decreasing of lacto- and bifidobacteria that may indicate a dysbiotic condition. Coadministration of chondroitin sulfate and probiotic bacteria has led to improvement the quantitative composition of the gut microbiota in experimental animals, the numerous of Bifidobacterium, Lactobacillus were increasing against decreasing the quantitative composition of opportunistic microorganisms. Conclusions. Monoiodoacetate-induced osteoarthritis caused dysbiosis of gut in rat. We observed beneficial effect of combined administration of chondroitin sulfate and probiotics on gut microbiota composition in rats with experimental osteoarthritis. Thus, adding of supplements like probiotics to standard treatment of osteoarthritis may have potentials to prevent and treat this disease.
The Effect of Probiotics on the Management of Pain and Inflammation in Osteoarthritis: A Systematic Review and Meta-Analysis of Clinical Studies

Maria Moyseos,Jenny Michael,Nuno Ferreira,Antonia Sophocleous

DOI: https://doi.org/10.3390/nu16142243

IF: 5.9

2024-07-13

Nutrients

Abstract:Osteoarthritis (OA) is one of the most common musculoskeletal disorders. Recently, research has focused on the role of intestinal microbiome dysbiosis in OA. The aim of this study was to systematically review randomized intervention clinical studies investigating the effect of probiotics on the management of OA-related pain and inflammation. Pre-clinical studies and non-randomized trials were excluded. A literature search was conducted using MEDLINE, EMBASE, and Web of Science. Study quality was assessed with the Cochrane risk of bias (RoB2) tool and the Risk of Bias in N-of-1 Trials (RoBiNT) scale. RevMan was used for the meta-analysis. Outcome measures assessed self-reported pain, stiffness and impediment, and serum hs-CRP. Three studies, with 501 participants, were considered eligible for qualitative synthesis and meta-analysis. A significant reduction in symptoms across all outcomes measured, except stiffness, was evident with Lactobacillus casei Shirota. However, all other probiotics reviewed did not seem to have any effect on the measured outcomes. Pre-clinical evidence, along with the RCTs reviewed, suggests that probiotics of the Lactobacillus strains might be of use for managing pain and inflammation in OA. Considering the small number of studies included in the present review and the possible risk of bias, we conclude that further studies on the role of probiotics in humans with OA are warranted.

nutrition & dietetics
The Association between Gut Microbiota and Osteoarthritis: Does the Disease Begin in the Gut?

Luciano C. Ramires,Gabriel Silva Santos,Rafaela Pereira Ramires,Lucas Furtado da Fonseca,Madhan Jeyaraman,Sathish Muthu,Anna Vitória Lana,Gabriel Azzini,Curtis Scott Smith,José Fábio Lana

DOI: https://doi.org/10.3390/ijms23031494

IF: 5.6

2022-01-27

International Journal of Molecular Sciences

Abstract:Some say that all diseases begin in the gut. Interestingly, this concept is actually quite old, since it is attributed to the Ancient Greek physician Hippocrates, who proposed the hypothesis nearly 2500 years ago. The continuous breakthroughs in modern medicine have transformed our classic understanding of the gastrointestinal tract (GIT) and human health. Although the gut microbiota (GMB) has proven to be a core component of human health under standard metabolic conditions, there is now also a strong link connecting the composition and function of the GMB to the development of numerous diseases, especially the ones of musculoskeletal nature. The symbiotic microbes that reside in the gastrointestinal tract are very sensitive to biochemical stimuli and may respond in many different ways depending on the nature of these biological signals. Certain variables such as nutrition and physical modulation can either enhance or disrupt the equilibrium between the various species of gut microbes. In fact, fat-rich diets can cause dysbiosis, which decreases the number of protective bacteria and compromises the integrity of the epithelial barrier in the GIT. Overgrowth of pathogenic microbes then release higher quantities of toxic metabolites into the circulatory system, especially the pro-inflammatory cytokines detected in osteoarthritis (OA), thereby promoting inflammation and the initiation of many disease processes throughout the body. Although many studies link OA with GMB perturbations, further research is still needed.

biochemistry & molecular biology,chemistry, multidisciplinary

Genome analysis and polar tube firing dynamics of mosquito-infecting microsporidia.

Vitamin E limits AAA.

The gut microbiota in osteoarthritis: where do we stand and what can we do?

Gut microbiota and osteoarthritis management: An expert consensus of the European society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO)

Association Between Gut Microbiota and Osteoarthritis: A Review of Evidence for Potential Mechanisms and Therapeutics

The Gut-Joint Axis in Osteoarthritis

The effects and significance of gut microbiota and its metabolites on the regulation of osteoarthritis: Close coordination of gut-bone axis

Gut-joint axis: Oral Probiotic ameliorates Osteoarthritis

The gut microbiome-joint connection: implications in osteoarthritis

The immune role of the intestinal microbiome in knee osteoarthritis: a review of the possible mechanisms and therapies

[Evaluation of the results of fluoridation of rat teeth by impregnation and electrophoresis].

Potential efficacy of gut microbiome dysbiosis on alleviation the progress of osteoarthritis in mice

Gut permeability and osteoarthritis, towards a mechanistic understanding of the pathogenesis: a systematic review

The Microbiome in Osteoarthritis: a Narrative Review of Recent Human and Animal Model Literature

Resonant effects in periodic gratings comprising a finite number of grooves in each period.

"Cross-talk" between gut microbiome dysbiosis and osteoarthritis progression: a systematic review

Identification and initial characterization of small cells in adult cartilage and bone marrow.

Gut Microbiome Dysbiosis Alleviates He Progression Of Osteoarthritis In Mice

The Gut Microbiota of Rats under Experimental Osteoarthritis and Administration of Chondroitin Sulfate and Probiotic

The Effect of Probiotics on the Management of Pain and Inflammation in Osteoarthritis: A Systematic Review and Meta-Analysis of Clinical Studies

The Association between Gut Microbiota and Osteoarthritis: Does the Disease Begin in the Gut?